Executive summary: Prevention of thromboembolic events: the role of point of care management.
D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D005060:Europe; D019317:Evidence-Based Medicine; D005858:Germany; D006349:Heart Valve Diseases / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D019934:International Normalized Ratio; D019095:Point-of-Care Systems / Q000592:standards*; D013923:Thromboembolism / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D015912:Thrombolytic Therapy / Q000379:methods / Q000592:standards
D000925:Anticoagulants; D000959:Antihypertensive Agents